Erlich et al. further demonstrated that specific PON1 polymorphisms are linked to an increased risk of Alzheimer’s disease, reinforcing the enzyme’s involvement in neurodegeneration [51]. This evidence concerns the gene PON1 and early-onset autosomal dominant Alzheimer disease.